Lam Research Co. (NASDAQ:LRCX) Receives $811.68 Consensus Price Target from Analysts

Shares of Lam Research Co. (NASDAQ:LRCX) have been assigned an average rating of “Moderate Buy” from the twenty-one brokerages that are covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $811.68.

Several research firms have recently weighed in on LRCX. Raymond James raised their price target on shares of Lam Research from $850.00 to $950.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Cantor Fitzgerald restated a “neutral” rating and set a $900.00 target price on shares of Lam Research in a report on Monday, March 4th. Stifel Nicolaus increased their price target on Lam Research from $850.00 to $950.00 and gave the company a “buy” rating in a report on Thursday, January 25th. Morgan Stanley lowered Lam Research from an “overweight” rating to an “equal weight” rating and set a $720.00 price objective on the stock. in a research note on Friday, December 8th. Finally, Citigroup raised their target price on Lam Research from $800.00 to $975.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th.

Lam Research Trading Up 0.6 %

Shares of NASDAQ:LRCX opened at $971.57 on Friday. The firm has a market capitalization of $127.37 billion, a price-to-earnings ratio of 37.57, a price-to-earnings-growth ratio of 3.44 and a beta of 1.51. The business’s 50 day moving average price is $907.49 and its 200-day moving average price is $762.59. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.06 and a quick ratio of 2.02. Lam Research has a 1 year low of $480.45 and a 1 year high of $1,007.39.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 EPS for the quarter, beating analysts’ consensus estimates of $7.06 by $0.46. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the prior year, the firm earned $10.71 earnings per share. The business’s revenue was down 28.8% compared to the same quarter last year. On average, equities research analysts forecast that Lam Research will post 28.88 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th will be given a dividend of $2.00 per share. The ex-dividend date is Tuesday, March 12th. This represents a $8.00 annualized dividend and a dividend yield of 0.82%. Lam Research’s dividend payout ratio is presently 30.94%.

Insider Activity at Lam Research

In other Lam Research news, CAO Christina Corrreia sold 647 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $768.75, for a total transaction of $497,381.25. Following the sale, the chief accounting officer now directly owns 5,492 shares in the company, valued at approximately $4,221,975. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, CAO Christina Corrreia sold 647 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total value of $497,381.25. Following the sale, the chief accounting officer now directly owns 5,492 shares in the company, valued at $4,221,975. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Timothy Archer sold 10,524 shares of the business’s stock in a transaction on Wednesday, January 3rd. The stock was sold at an average price of $732.00, for a total value of $7,703,568.00. Following the transaction, the chief executive officer now directly owns 86,449 shares of the company’s stock, valued at $63,280,668. The disclosure for this sale can be found here. Over the last quarter, insiders sold 19,895 shares of company stock worth $15,666,586. Corporate insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Arlington Trust Co LLC lifted its position in shares of Lam Research by 7.7% during the 4th quarter. Arlington Trust Co LLC now owns 182 shares of the semiconductor company’s stock worth $143,000 after purchasing an additional 13 shares during the last quarter. Capital Performance Advisors LLP raised its stake in Lam Research by 2.2% in the fourth quarter. Capital Performance Advisors LLP now owns 613 shares of the semiconductor company’s stock valued at $480,000 after buying an additional 13 shares in the last quarter. Van Leeuwen & Company LLC boosted its position in shares of Lam Research by 0.5% during the 4th quarter. Van Leeuwen & Company LLC now owns 2,583 shares of the semiconductor company’s stock worth $2,023,000 after acquiring an additional 13 shares in the last quarter. CNB Bank increased its holdings in shares of Lam Research by 1.4% in the 4th quarter. CNB Bank now owns 1,032 shares of the semiconductor company’s stock valued at $808,000 after acquiring an additional 14 shares during the last quarter. Finally, Tradition Wealth Management LLC raised its position in shares of Lam Research by 0.7% during the 4th quarter. Tradition Wealth Management LLC now owns 2,010 shares of the semiconductor company’s stock worth $1,574,000 after acquiring an additional 14 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.